Peter Nielsen

Vivostat A/S

Vivostat® develop, manufacture and market the Vivostat® system, which is sold through direct sales channels and distributors throughout Europe, Asia and the Middle East. The uniqueness of the Vivostat® system is a novel patented biotechnological process that enables reliable and reproducible preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF®) to prevent/stop bleeding or stimulate the healing of chronic wounds. With the Vivostat® system It is also possible to co-deliver a desired antibiotic with Vivostat® Fibrin Sealant or Vivostat PRF®. The fully automated Vivostat® system consists of three components: 1. The Processor Unit The Processor Unit is used to process the patient's blood and prepare the Vivostat® Fibrin Sealant or Vivostat PRF® solution. 2. The Applicator Unit The Applicator Unit controls the delivery of the Vivostat® solution to the site of treatment. 3. The Disposable Set The single-use set contains all components needed for preparation and application of Vivostat® Fibrin Sealant or Vivostat PRF®. It is available with a range of application devices each optimised for different types of applications. The Vivostat® system can be used in many clinical applications including but not limited to; cardiac, thoracic, orthopedic and neurosurgery as well as in wound healing treatment. For more information on the Vivostat® system visit the company website at: http://www.vivostat.com/products For questions or inquiries contact Vivostat by e-mail at: info@vivostat.com If you want to be a distributor please go to http://www.vivostat.com/your-contact and find a contact in your area